{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "CITIUS PHARMAC.  DL -,001", "longName": "Citius Pharmaceuticals, Inc.", "messageBoardId": "finmb_272471835", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": 4.382117, "regularMarketPrice": 1.191, "marketState": "REGULAR", "firstTradeDateMilliseconds": 1589349600000, "priceHint": 4, "epsTrailingTwelveMonths": -0.18, "epsForward": -0.15, "epsCurrentYear": -0.25, "priceEpsCurrentYear": -4.764, "sharesOutstanding": 146258000, "bookValue": 0.687, "fiftyDayAverage": 1.126804, "fiftyDayAverageChange": 0.06419599, "fiftyDayAverageChangePercent": 0.056971747, "twoHundredDayAverage": 1.1018845, "twoHundredDayAverageChange": 0.0891155, "twoHundredDayAverageChangePercent": 0.08087554, "marketCap": 177356576, "forwardPE": -7.9399996, "priceToBook": 1.7336245, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": 0.049999952, "regularMarketTime": 1683871252, "regularMarketDayHigh": 1.191, "regularMarketDayRange": "1.191 - 1.191", "regularMarketDayLow": 1.191, "regularMarketVolume": 1920, "regularMarketPreviousClose": 1.141, "bid": 1.23, "ask": 1.279, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 1.191, "averageDailyVolume3Month": 166, "averageDailyVolume10Day": 192, "fiftyTwoWeekLowChange": 0.4659, "fiftyTwoWeekLowChangePercent": 0.6425321, "fiftyTwoWeekRange": "0.7251 - 1.484", "fiftyTwoWeekHighChange": -0.29299998, "fiftyTwoWeekHighChangePercent": -0.19743934, "fiftyTwoWeekLow": 0.7251, "fiftyTwoWeekHigh": 1.484, "earningsTimestamp": 1676064602, "earningsTimestampStart": 1683889140, "earningsTimestampEnd": 1684152000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "47N.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "11 Commerce Drive", "address2": "First Floor", "city": "Cranford", "state": "NJ", "zip": "07016", "country": "United States", "phone": "908 967 6677", "website": "https://www.citiuspharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Citius Pharmaceuticals, Inc., a late-stage pharmaceutical company, engages in the development and commercialization of critical care products focusing on oncology products, anti-infectives products in adjunct cancer care, prescription products, and stem cell therapy. It is developing five proprietary products comprising I/ONTAK, an engineered IL-2 diphtheria toxin fusion protein for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma; Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected catheter; Halo-Lido, a corticosteroid-lidocaine topical formulation that intends to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; and NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome. The company was founded in 2007 and is headquartered in Cranford, New Jersey.", "fullTimeEmployees": 21, "companyOfficers": [{"maxAge": 1, "name": "Mr. Leonard L. Mazur", "age": 77, "title": "Co-Founder, CEO, Chairman & Sec.", "yearBorn": 1945, "fiscalYear": 2022, "totalPay": {"raw": 570000, "fmt": "570k", "longFmt": "570,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 76333, "fmt": "76.33k", "longFmt": "76,333"}}, {"maxAge": 1, "name": "Mr. Myron Z. Holubiak", "age": 75, "title": "Co-Founder & Exec. Vice Chairman", "yearBorn": 1947, "fiscalYear": 2022, "totalPay": {"raw": 620000, "fmt": "620k", "longFmt": "620,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 76333, "fmt": "76.33k", "longFmt": "76,333"}}, {"maxAge": 1, "name": "Mr. Jaime  Bartushak", "age": 54, "title": "Chief Bus. Officer, CFO & Chief Accounting Officer", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 527967, "fmt": "527.97k", "longFmt": "527,967"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 44333, "fmt": "44.33k", "longFmt": "44,333"}}, {"maxAge": 1, "name": "Dr. Myron S. Czuczman M.D.", "age": 62, "title": "Exec. VP & Chief Medical Officer", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": {"raw": 550917, "fmt": "550.92k", "longFmt": "550,917"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 7500, "fmt": "7.5k", "longFmt": "7,500"}}, {"maxAge": 1, "name": "Mr. Gary F. Talarico", "age": 67, "title": "Exec. VP of Operations", "yearBorn": 1955, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Ilanit  Allen", "title": "VP of Investor Relations & Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Alan  Lader Ph.D.", "title": "Sr. VP and Head of Clinical Operations & Quality Assurance", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Dhananjay G. Wadekar", "age": 68, "title": "Sr. VP of Bus. Strategy", "yearBorn": 1954, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Kelly  Creighton Ph.D.", "title": "Exec. VP of Chemistry, Manufacturing & Controls", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Nikolas  Burlew", "title": "Exec. VP of Quality Assurance", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}